Business & Economics

Blog

The June Primary is Over. So, What Now?

Now that the June primary is behind us, pundits and political observers are on overdrive telling us what it all means and what we can expect from the fall campaign. Perhaps we should all pause before writing the June primary’s eulogy as hundreds of thousands of votes remain to be ...
Blog

Would Public Employees Really Lose Income After Janus Ruling?

Public-sector employees who want to be freed of forced unionization are hoping that the Supreme Court will release them from their yoke when it issues its impending ruling in the case of a government worker who sued the union that claims to represent him. Others, though, fear a future in ...
Business & Economics

Wayne Winegarden Discusses Trump Tax Cuts with TheStreet.com

Tax-Cut-Fueled Stock Buybacks Retard Emergence of Trump’s ‘Greatest’ Economy By Bradley Keoun President Donald Trump’s tax cuts have prompted corporate executives use the cash windfall to reward their own investors instead of building factories, buying new equipment or accelerating wage increases that might spur consumer spending and stimulate the U.S. economy. ...
Blog

Free Markets 101: Free Markets Enable Prosperity and Compassion

The U.S. economy has generated more wealth for more people than any other economic system in human history, and it’s not even close. What began as a small group of colonies clustered near the eastern seaboard of a mostly empty continent founded by political and religious refugees somehow become more ...
Business & Economics

Embracing Competition To Empower Biosimilars

In 2017, there were 46 new novel drug innovations, including new treatments for cancers, Parkinson’s disease, and serious skin infections. These innovations are essential for improving the quality of health care in the U.S. However, innovation is not sufficient. It is equally imperative to promote drug affordability through greater competition. Promoting ...
Business & Economics

New Study: Patients, Employers and Taxpayers Could Save Significantly if Barriers to Biosimilars Removed

A new study released today found that, by removing barriers holding back the increased use of biosimilars, savings could be significant. In a case study of infliximab, used to treat rheumatoid arthritis, Crohn’s disease, and other illnesses, reforms could realize an annual savings of between $412 million and $465 million. ...
Blog

Assembly Offers $120 million Bait to UC to Stop 401(k) plans

The great investor Warren Buffett once said, “Should you find yourself in a chronically leaking boat, energy devoted to changing vessels is likely to be more productive than energy devoted to patching leaks.”  UC President Janet Napolitano probably had similar thoughts when she wrote to the Assembly opposing their offer ...
Blog

When the Public Option Is the Only Option

Single-payer has failed abroad and at home. Yet the call for single-payer from progressives has never been louder. Vermont senator Bernie Sanders (I-VT) and his dedicated followers have been the loudest. In his campaign for the Democratic presidential nomination in 2016, he promised “Medicare for All.” In September 2017, he ...
Blog

The Anti-Growth Tariffs Are a Clear and Present Danger to Our Future Economic Prosperity

Without a hint of irony, while announcing the 25 percent tariffs on imported steel and the 10 percent tariffs on imported aluminum on May 31st, Commerce Secretary Ross proclaimed that “we take the view that without a strong economy, you cannot have strong national security”. In reality, these tariffs will ...
Business & Economics

Starbucks’ Inclusive Culture Results in Lingerers

By Brendan Pringle This afternoon some 8,000 Starbucks stores in the United States shut down for “racial-bias education” to prevent discrimination in its stores. Starbucks remains under fire after the arrest of two black men after they refused to leave or make a purchase.  The training is said to include a ...
Blog

The June Primary is Over. So, What Now?

Now that the June primary is behind us, pundits and political observers are on overdrive telling us what it all means and what we can expect from the fall campaign. Perhaps we should all pause before writing the June primary’s eulogy as hundreds of thousands of votes remain to be ...
Blog

Would Public Employees Really Lose Income After Janus Ruling?

Public-sector employees who want to be freed of forced unionization are hoping that the Supreme Court will release them from their yoke when it issues its impending ruling in the case of a government worker who sued the union that claims to represent him. Others, though, fear a future in ...
Business & Economics

Wayne Winegarden Discusses Trump Tax Cuts with TheStreet.com

Tax-Cut-Fueled Stock Buybacks Retard Emergence of Trump’s ‘Greatest’ Economy By Bradley Keoun President Donald Trump’s tax cuts have prompted corporate executives use the cash windfall to reward their own investors instead of building factories, buying new equipment or accelerating wage increases that might spur consumer spending and stimulate the U.S. economy. ...
Blog

Free Markets 101: Free Markets Enable Prosperity and Compassion

The U.S. economy has generated more wealth for more people than any other economic system in human history, and it’s not even close. What began as a small group of colonies clustered near the eastern seaboard of a mostly empty continent founded by political and religious refugees somehow become more ...
Business & Economics

Embracing Competition To Empower Biosimilars

In 2017, there were 46 new novel drug innovations, including new treatments for cancers, Parkinson’s disease, and serious skin infections. These innovations are essential for improving the quality of health care in the U.S. However, innovation is not sufficient. It is equally imperative to promote drug affordability through greater competition. Promoting ...
Business & Economics

New Study: Patients, Employers and Taxpayers Could Save Significantly if Barriers to Biosimilars Removed

A new study released today found that, by removing barriers holding back the increased use of biosimilars, savings could be significant. In a case study of infliximab, used to treat rheumatoid arthritis, Crohn’s disease, and other illnesses, reforms could realize an annual savings of between $412 million and $465 million. ...
Blog

Assembly Offers $120 million Bait to UC to Stop 401(k) plans

The great investor Warren Buffett once said, “Should you find yourself in a chronically leaking boat, energy devoted to changing vessels is likely to be more productive than energy devoted to patching leaks.”  UC President Janet Napolitano probably had similar thoughts when she wrote to the Assembly opposing their offer ...
Blog

When the Public Option Is the Only Option

Single-payer has failed abroad and at home. Yet the call for single-payer from progressives has never been louder. Vermont senator Bernie Sanders (I-VT) and his dedicated followers have been the loudest. In his campaign for the Democratic presidential nomination in 2016, he promised “Medicare for All.” In September 2017, he ...
Blog

The Anti-Growth Tariffs Are a Clear and Present Danger to Our Future Economic Prosperity

Without a hint of irony, while announcing the 25 percent tariffs on imported steel and the 10 percent tariffs on imported aluminum on May 31st, Commerce Secretary Ross proclaimed that “we take the view that without a strong economy, you cannot have strong national security”. In reality, these tariffs will ...
Business & Economics

Starbucks’ Inclusive Culture Results in Lingerers

By Brendan Pringle This afternoon some 8,000 Starbucks stores in the United States shut down for “racial-bias education” to prevent discrimination in its stores. Starbucks remains under fire after the arrest of two black men after they refused to leave or make a purchase.  The training is said to include a ...
Scroll to Top